Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

American Healthcare REIT (AHR) Change in Accured Expenses (2016 - 2025)

American Healthcare REIT (AHR) has disclosed Change in Accured Expenses for 10 consecutive years, with $1.4 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Change in Accured Expenses rose 116.43% year-over-year to $1.4 million, compared with a TTM value of $29.0 million through Dec 2025, up 4543.03%, and an annual FY2025 reading of $29.0 million, up 4543.03% over the prior year.
  • Change in Accured Expenses was $1.4 million for Q4 2025 at American Healthcare REIT, down from $10.8 million in the prior quarter.
  • Across five years, Change in Accured Expenses topped out at $17.0 million in Q3 2023 and bottomed at -$18.6 million in Q3 2021.
  • Average Change in Accured Expenses over 5 years is $1.3 million, with a median of $2.0 million recorded in 2021.
  • The sharpest move saw Change in Accured Expenses crashed 2325.61% in 2021, then soared 1646.26% in 2025.
  • Year by year, Change in Accured Expenses stood at -$5.3 million in 2021, then soared by 188.04% to $4.7 million in 2022, then tumbled by 34.39% to $3.1 million in 2023, then crashed by 385.98% to -$8.7 million in 2024, then surged by 116.43% to $1.4 million in 2025.
  • Business Quant data shows Change in Accured Expenses for AHR at $1.4 million in Q4 2025, $10.8 million in Q3 2025, and $3.7 million in Q2 2025.